Literature DB >> 24262509

Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy.

Guangchang Pei1, Rui Zeng, Min Han, Panli Liao, Xuan Zhou, Yueqiang Li, Ying Zhang, Ping Liu, Chunxiu Zhang, XiaoCheng Liu, Ying Yao, Gang Xu.   

Abstract

BACKGROUND AND OBJECTIVES: Previous studies have identified inflammatory features that enable the prediction of renal outcome of IgA nephropathy (IgAN); however, validation of these findings is still needed. This prospective study was performed to determine the characteristics of renal interstitial infiltration and tertiary lymphoid organ (TLO) neogenesis in a cohort of Chinese patients with IgAN. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adult patients with IgAN were recruited into this study from June 2009 to June 2010. Inflammatory cells in renal biopsy tissues were detected by immunohistochemistry and immunofluorescence. Correlations between the density of interstitial inflammatory cells, grades of TLOs, and clinicopathologic features were evaluated. Of 152 eligible patients, 72 (47%) were successfully followed-up by telephone at 30 months after renal biopsy. Twelve patients were classified as the severe group and 60 patients were classified as the stable group, according to the progression of serum creatinine levels during the follow-up period. A comparison of the severity of interstitial infiltration and the frequency of TLO neogenesis between the two groups was performed.
RESULTS: The accumulation of interstitial inflammatory cells was correlated with decreased renal function, heavy proteinuria, and severe glomerular, interstitial, and arterial lesions in patients with IgAN. TLOs, identified as nodular inflammatory infiltrates containing organized DC-SIGN(+), CD4(+), CD8(+), and CD20(+) cells, were observed in 37.5% of patients. Patients with high-grade TLOs exhibited a high percentage of mesangial hypercellularity and crescents as well as severe interstitial and arterial lesions. Patients in the severe group exhibited more severe interstitial infiltration and a higher percentage of TLO neogenesis (83.3% versus 33.3%; P=0.001) compared with patients in the stable group.
CONCLUSIONS: As contributors to an active local inflammatory response, the severity of interstitial infiltration and the frequency of TLO neogenesis are correlated with glomerular, interstitial, and arterial lesions as well as IgAN progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24262509      PMCID: PMC3913227          DOI: 10.2215/CJN.01150113

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

Review 1.  Memory B cells and CD27.

Authors:  K Agematsu
Journal:  Histol Histopathol       Date:  2000-04       Impact factor: 2.303

Review 2.  Ectopic lymphoid organogenesis: a fast track for autoimmunity.

Authors:  C M Weyand; P J Kurtin; J J Goronzy
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

3.  The contribution of B cells to renal interstitial inflammation.

Authors:  Florian Heller; Maja T Lindenmeyer; Clemens D Cohen; Ulrike Brandt; Dan Draganovici; Michael Fischereder; Matthias Kretzler; Hans-Joachim Anders; Thomas Sitter; Isabella Mosberger; Dontscho Kerjaschki; Heinz Regele; Detlef Schlöndorff; Stephan Segerer
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Authors:  Tatjana Marinkovic; Alexandre Garin; Yoshifumi Yokota; Yang-Xin Fu; Nancy H Ruddle; Glaucia C Furtado; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

5.  Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis.

Authors:  Joëlle Marchal-Sommé; Yurdagul Uzunhan; Sylvain Marchand-Adam; Dominique Valeyre; Vassili Soumelis; Bruno Crestani; Paul Soler
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

6.  Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies.

Authors:  Lei-Shi Li; Zhi-Hong Liu
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.

Authors:  V Rauta; P Finne; J Fagerudd; K Rosenlöf; T Törnroth; C Grönhagen-Riska
Journal:  Clin Nephrol       Date:  2002-08       Impact factor: 0.975

8.  Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.

Authors:  James V Donadio; Erik J Bergstralh; Joseph P Grande; Diana M Rademcher
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

Review 9.  IgA nephropathy.

Authors:  J H Galla
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

Review 10.  Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome.

Authors:  Giuseppe D'Amico
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

View more
  25 in total

Review 1.  B lymphocytes in renal interstitial fibrosis.

Authors:  Fengge Zhu; Xueyuan Bai; Xiangmei Chen
Journal:  J Cell Commun Signal       Date:  2017-02-16       Impact factor: 5.782

2.  Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival.

Authors:  Ibrahim Batal; Sacha A De Serres; Kassem Safa; Vanesa Bijol; Takuya Ueno; Maristela L Onozato; A John Iafrate; Jan M Herter; Andrew H Lichtman; Tanya N Mayadas; Indira Guleria; Helmut G Rennke; Nader Najafian; Anil Chandraker
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  Identification and Quantitation of Leukocyte Populations in Human Kidney Tissue by Multi-parameter Flow Cytometry.

Authors:  Katrina Kildey; Becker M P Law; Kimberly A Muczynski; Ray Wilkinson; Healy Helen; Andrew J Kassianos
Journal:  Bio Protoc       Date:  2018-08-20

4.  Tertiary lymphoid tissues in kidney diseases: a perspective for the pediatric nephrologist.

Authors:  Takahisa Yoshikawa; Yu Ho Lee; Yuki Sato; Motoko Yanagita
Journal:  Pediatr Nephrol       Date:  2022-10-17       Impact factor: 3.651

5.  Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney.

Authors:  Yuki Sato; Akiko Mii; Yoko Hamazaki; Harumi Fujita; Hirosuke Nakata; Kyoko Masuda; Shingo Nishiyama; Shinsuke Shibuya; Hironori Haga; Osamu Ogawa; Akira Shimizu; Shuh Narumiya; Tsuneyasu Kaisho; Makoto Arita; Masashi Yanagisawa; Masayuki Miyasaka; Kumar Sharma; Nagahiro Minato; Hiroshi Kawamoto; Motoko Yanagita
Journal:  JCI Insight       Date:  2016-07-21

Review 6.  The Role of Lymphoid Neogenesis in Allografts.

Authors:  H-M Hsiao; W Li; A E Gelman; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

7.  TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.

Authors:  Nuoyan Zheng; Kaifeng Xie; Hongjian Ye; Yu Dong; Bing Wang; Ning Luo; Jinjin Fan; Jiaqing Tan; Wei Chen; Xueqing Yu
Journal:  JCI Insight       Date:  2020-07-23

8.  NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.

Authors:  Yu-Ling Tsai; Kuo-Feng Hua; Ann Chen; Chyou-Wei Wei; Wen-Shiang Chen; Cheng-Yeu Wu; Ching-Liang Chu; Yung-Luen Yu; Chia-Wen Lo; Shuk-Man Ka
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

9.  Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling.

Authors:  M Zhang; Y Guo; H Fu; S Hu; J Pan; Y Wang; J Cheng; J Song; Q Yu; S Zhang; J-F Xu; G Pei; X Xiang; P Yang; C-Y Wang
Journal:  Cell Death Dis       Date:  2015-08-06       Impact factor: 8.469

Review 10.  Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung.

Authors:  Ji Young Hwang; Troy D Randall; Aaron Silva-Sanchez
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.